DNA vaccination via in vivo electroporation can elicit specific immune response against highly pathogenic H5N1 influenza viral structural antigens in mice.
- Author:
Wen WANG
1
;
Hong CHEN
;
Wen-jie TAN
;
Yao DENG
;
Min WANG
;
Yuan LIU
;
Xiao YIN
;
Ke ZHANG
;
Jie GUAN
;
Jian-fang ZHOU
;
Yue-long SHU
;
Li RUAN
Author Information
1. National Institute for Viral Disease Control and Prevention, China CDC, Beijing 100052, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Antigens, Viral;
immunology;
Codon;
genetics;
Electroporation;
Female;
Humans;
Influenza A Virus, H5N1 Subtype;
immunology;
Mice;
Mice, Inbred BALB C;
Vaccination;
methods;
Vaccines, DNA;
genetics;
immunology;
metabolism;
Viral Structural Proteins;
immunology
- From:
Chinese Journal of Virology
2010;26(3):170-175
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to develop inexpensive and effective experimental vaccines against highly pathogenic H5N1 Avian Influenza (HPAI) virus and to optimize their immunization programs. To this end, we first synthesized the codon-optimized hemagglutinin gene (HAop) and neuraminidase gene (NAop), both of which were derived from a H5N1 virus (Anhui strain), and constructed successfully the DNA vaccines containing a single cistronic construct (HAwt, HAop, or NAop) or a bicistronic construct (HAop/M2 or NAop/M1) of H5N1 influenza virus origin. Their expression was confirmed by indirect immunofluorescent assay (IFA) and Western blotting. Then twice vaccination of mice with the DNA vaccines by injection intramuscularly or in vivo electroporation (EP) via two different routes was evaluated and analyzed by hemagglutination inhibition (HI) assay, NA-specific antibody detection, micro-neutralizing antibody test and IFN-gamma ELISpot assay. Our results showed that the DNA vaccines with coden-optimized HAop and NAop constructs could quickly elicit a strong immune response by in vivo EP, especially the cellular immune response against HA and NA; the in vivo EP via intradermal route induced stronger humoral immune responses than those via intramuscular route. Our findings will pave a way for further development of novel DNA-based H5N1 vaccine and for the optimization of the immunization programs of DNA vaccine.
